Evaluation of Cytotoxic and Apoptotic Effects of Methotrexate and Carvacrol Combination in Lung Cancer Cancer Cells

Basit Öğe Kaydı
dc.contributor.authorErdogan, Ayse
dc.date.accessioned2026-01-24T12:00:53Z
dc.date.available2026-01-24T12:00:53Z
dc.date.issued2025
dc.departmentAlanya Alaaddin Keykubat Üniversitesi
dc.description.abstractThe aim of this study is to compare the cytotoxic and apoptotic effects of methotrexate (MTX),one of chemotherapy drug, alone application with the combined application of MTX and carvacrol, a naturally occurring monoterpenoid phenol, in lung cancer cells. Cell viability was assessed using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazoliumbromide (MTT) assay after A-549 cells were treated with MTX alone and in combination with carvacrol for 48 h. Lactate dehydrogenase (LDH) activity test was employed to assess whether MTX alone or in combination with carvacrol treatments, induced membrane damage by detecting changes in LDH activity in A-549 cells. Caspase-3 enzyme activity changes in cells were measured to show the apoptotic effect. By examining the alterations in glutathione peroxidase activity, an attempt was made to determine whether MTX, alone and in combination with carvacrol, played a role in inducing oxidative stress. It was observed that the combined application of MTX and carvacrol for 48 h inhibited cell proliferation more than MTX alone treatment, demonstrating a stronger cytotoxic effect. Additionally, it caused a greater increase in LDH activity, a marker of membrane damage, and also led to a higher increase in caspase-3 activity, an enzyme involved in the apoptotic pathway. The results of this study show that the combined application of MTX and carvacrol leads to a greater increase in LDH activity and caspase-3 activity compared to MTX alone treatment, indicating more significant membrane damage and apoptotic effects. Therefore, combined treatment could be considered a strategy for alleviating the side effects associated with MTX in lung cancer.
dc.identifier.doi10.35414/akufemubid.1617388
dc.identifier.endpage1000
dc.identifier.issn2149-3367
dc.identifier.issue5
dc.identifier.startpage990
dc.identifier.trdizinid1348963
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1348963
dc.identifier.urihttps://doi.org/10.35414/akufemubid.1617388
dc.identifier.urihttps://hdl.handle.net/20.500.12868/3807
dc.identifier.volume25
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofAfyon Kocatepe Üniversitesi Fen ve Mühendislik Bilimleri Dergisi
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_TR-Dizin_20260121
dc.subjectMethotrexate
dc.subjectLung cancer
dc.subjectCarvacrol
dc.subjectApoptotic effect
dc.subjectCombined treatment
dc.titleEvaluation of Cytotoxic and Apoptotic Effects of Methotrexate and Carvacrol Combination in Lung Cancer Cancer Cells
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
10.35414-akufemubid.1617388-4510207.pdf
Boyut:
1.24 MB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu